| Product ID |
CAS Number |
Product Name |
Quantity |
| AS-0081 |
939-80-0 |
4-CHLORO-3-NITROBENZONITRILE |
|
| AS-0083 |
840481-82-5 |
Benzonitrile, 3-bromo-2-fluoro- (9CI) |
|
| AS-0243 |
55934-00-4 |
3,4-Dichloropyridine |
|
| AS-0722 |
3731-52-0 |
3-(Aminomethyl)pyridine |
|
| AS-0979 |
2973-59-3 |
2-Bromoisovanillin |
|
| AS-1401 |
78663-07-7 |
N-Benzyloxycarbonyl-D-aspartic acid |
|
| AS-2107 |
452-73-3 |
2-Chloro-4-fluorotoluene |
|
| AS-2319 |
3433-80-5 |
2-Bromobenzyl bromide |
|
| AS-2548 |
89284-20-8 |
3-CHLORO-4-HYDROXYPYRIDINE |
|
| AS-2605 |
16588-34-4 |
4-Chloro-3-nitrobenzaldehyde |
|
| AS-2700 |
76179-40-3 |
1,2-DIAMINO-4,5-DIFLUOROBENZENE |
|
| AS-2832 |
613660-87-0 |
4-(Aminosulfonyl)phenylboronic acid |
|
| AS-2841 |
71597-85-8 |
4-Hydroxyphenylboronic acid |
|
| AS-3548 |
15663-27-1 |
Cisplatin |
|
| AS-4733 |
89-71-4 |
Methyl o-toluate |
|
| AS-4773 |
3607-17-8 |
(3-BROMOPROPYL)TRIPHENYLPHOSPHONIUM BROMIDE |
|
| AS-5026 |
877-43-0 |
2,6-DIMETHYLQUINOLINE |
|
| AS-5084 |
95-51-2 |
2-Chloroaniline |
|
| AS-5117 |
16851-82-4 |
1-(PHENYLSULFONYL)PYRROLE |
|
| AS-5124 |
64431-96-5 |
1,3-Bis[tris(hydroxymethyl)methylamino]propane |
|
| AS-5244 |
402-45-9 |
4-Trifluoromethylphenol |
|
| AS-6047 |
58534-94-4 |
3-BROMO-2-FLUORONITROBENZENE |
|
| AS-6584 |
641-70-3 |
3-Nitrophthalic anhydride |
|
| AS-6586 |
2039-86-3 |
3-Bromostyrene |
|
| AS-6621 |
3398-16-1 |
4-Bromo-3,5-dimethylpyrazole |
|
| AS-6847 |
489430-50-4 |
4-CHLOROSULFONYL-PYRIDINIUM, CHLORIDE |
|
| AS-6963 |
539-48-0 |
1,4-Bis(aminomethyl)benzene |
|
| AS-6980 |
60933-68-8 |
2,3,5-TRI-O-BENZYL-BETA-D-ARABINOFURANOSE |
|
| AS-7405 |
765-87-7 |
1,2-Cyclohexanedione |
|
| AS-7935 |
122996-47-8 |
Fmoc-4-tert-butoxy-L-proline |
|
| AS-7996 |
83105-70-8 |
Sultamicillin tosilate |
|
| AS-8541 |
518048-05-0 |
Raltegravir |
|
| AS-8580 |
5147-80-8 |
2-[DI(METHYLTHIO)METHYLIDENE]MALONONITRILE |
|
| AS-8853 |
5081-37-8 |
Methyl 3-methoxy-4-nitrobenzoate |
|
| AS-9112 |
641571-11-1 |
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline |
|
|
|
|
|
|
|
|
|
|
|
|
|